Transient Improvement after Switch to Low Doses of RimabotulinumtoxinB in Patients Resistant to AbobotulinumtoxinA

por Hefter, Harald, Samadzadeh, Sara, Moll, Marek
Publicado 2020

Clinical relevance of neutralizing antibodies in botulinum toxin long-term treated still-responding patients with cervical dystonia

por Hefter, Harald, Rosenthal, Dietmar, Bigalke, Hans, Moll, Marek
Publicado 2019

Prospective analysis of neutralising antibody titres in secondary non-responders under continuous treatment with a botulinumtoxin type A preparation free of complexing proteins—a s...

por Hefter, Harald, Hartmann, Christian, Kahlen, Ulrike, Moll, Marek, Bigalke, Hans
Publicado 2012

Clinical Improvement After Treatment With IncobotulinumtoxinA (XEOMIN®) in Patients With Cervical Dystonia Resistant to Botulinum Toxin Preparations Containing Complexing Proteins

por Hefter, Harald, Hartmann, Christian J., Kahlen, Ulrike, Samadzadeh, Sara, Rosenthal, Dietmar, Moll, Marek
Publicado 2021

Long‐term adherence and response to botulinum toxin in different indications

por Lee, John‐Ih, Jansen, Alexander, Samadzadeh, Sara, Kahlen, Ulrike, Moll, Marek, Ringelstein, Marius, Soncin, Giulia, Bigalke, Hans, Aktas, Orhan, Moldovan, Alexia‐Sabine, Waskoenig, Julia, Jander, Sebastian, Gliem, Michael, Schnitzler, Alfons, Hartung, Hans‐Peter, Hefter, Harald, Albrecht, Philipp
Publicado 2020